IL32922A - Multivalent live measles,mumps and rubella vaccine - Google Patents

Multivalent live measles,mumps and rubella vaccine

Info

Publication number
IL32922A
IL32922A IL32922A IL3292269A IL32922A IL 32922 A IL32922 A IL 32922A IL 32922 A IL32922 A IL 32922A IL 3292269 A IL3292269 A IL 3292269A IL 32922 A IL32922 A IL 32922A
Authority
IL
Israel
Prior art keywords
mumps
rubella vaccine
live measles
multivalent live
multivalent
Prior art date
Application number
IL32922A
Other languages
English (en)
Other versions
IL32922A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL32922A0 publication Critical patent/IL32922A0/xx
Publication of IL32922A publication Critical patent/IL32922A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0015Combination vaccines based on measles-mumps-rubella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18711Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL32922A 1968-09-11 1969-09-01 Multivalent live measles,mumps and rubella vaccine IL32922A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75923768A 1968-09-11 1968-09-11

Publications (2)

Publication Number Publication Date
IL32922A0 IL32922A0 (en) 1969-11-30
IL32922A true IL32922A (en) 1973-01-30

Family

ID=25054907

Family Applications (1)

Application Number Title Priority Date Filing Date
IL32922A IL32922A (en) 1968-09-11 1969-09-01 Multivalent live measles,mumps and rubella vaccine

Country Status (10)

Country Link
AT (1) AT291440B (de)
BE (1) BE738674A (de)
BR (1) BR6912333D0 (de)
DE (1) DE1944956A1 (de)
ES (1) ES371256A1 (de)
FR (1) FR2017790A1 (de)
IE (1) IE33311B1 (de)
IL (1) IL32922A (de)
NL (1) NL6913032A (de)
ZA (1) ZA695453B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633518B1 (fr) * 1988-06-30 1991-03-22 Merieux Inst Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues

Also Published As

Publication number Publication date
BR6912333D0 (pt) 1973-04-12
DE1944956A1 (de) 1970-03-19
AT291440B (de) 1971-07-12
ZA695453B (en) 1971-03-31
BE738674A (de) 1970-03-10
IL32922A0 (en) 1969-11-30
IE33311L (en) 1970-03-11
NL6913032A (de) 1970-03-13
FR2017790A1 (en) 1970-05-22
IE33311B1 (en) 1974-05-15
ES371256A1 (es) 1972-04-01

Similar Documents

Publication Publication Date Title
FI51449C (fi) Useiden esineiden määräasentoon pakkaamiseen aiottu menetelmä ja laite .
DK132898B (da) Vandoploseligt partikelformet rensemiddel og en fremgangsmadetil fremstilling heraf
IL32922A (en) Multivalent live measles,mumps and rubella vaccine
CA936095A (en) Rubella vaccine and method
SE383696B (sv) Kombinerad gjut- och smidesanordning
BE754523A (fr) Vaccins
BE773663A (fr) 1-alcenyl-9,10-anthraquinones et leurs preparation
IL32463A0 (en) 1-azacyclo-4-imino-1,4-dihydro-pyridines and their preparation
BE772010A (fr) Nouvelles 4-phenylcyclohexylamines, leurs intermediaires et leurs procedes de preparation
ZA715260B (en) 8-cyano-5-ocatanolide and method for the preparation thereof
ZA693919B (en) Animal vaccines and methods for using
BE785892A (fr) Electrofiltre, en particulier electrofiltre par voie humide
FI46863C (fi) Menetelmä antigeenia, adjuvanttia ja polynukleotidia sisältävän influe nssarokotteen valmistamiseksi
AU6032669A (en) Multivalent vaccines
AU2091370A (en) Improvements; in virus vaccines
IL28194A (en) Rubella vaccine and its preparation
CA798292A (en) Somatic antigen vaccines
ZM9369A1 (en) Animal vaccines and methods for using
CA835350A (en) Mumps vaccine
IE31475L (en) Rubella virus vaccine
CA778256A (en) Heat exchanger and method
BE764190A (fr) Colorants mono-azoiques hydrosolubles et leur
AU424740B2 (en) Vaccines
BE753723A (nl) Verbeterde brievenbuskonstruktie en profielen gebruikt bij deze konstruktie.
CA836529A (en) Vaccines against measles and process for their manufacture